Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis.

MLA

Hunter, S. F., et al. “Monoclonal Remyelination-Promoting Natural Autoantibody SCH 94.03: Pharmacokinetics and in Vivo Targets within Demyelinated Spinal Cord in a Mouse Model of Multiple Sclerosis.” Journal of the Neurological Sciences, vol. 150, no. 2, Sept. 1997, pp. 103–13. EBSCOhost, https://doi.org/10.1016/s0022-510x(97)00080-4.

APA

Hunter, S. F., Miller, D. J., & Rodriguez, M. (1997). Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. Journal of the Neurological Sciences, 150(2), 103–113. https://doi.org/10.1016/s0022-510x(97)00080-4

Chicago

Hunter, S F, D J Miller, and M Rodriguez. 1997. “Monoclonal Remyelination-Promoting Natural Autoantibody SCH 94.03: Pharmacokinetics and in Vivo Targets within Demyelinated Spinal Cord in a Mouse Model of Multiple Sclerosis.” Journal of the Neurological Sciences 150 (2): 103–13. doi:10.1016/s0022-510x(97)00080-4.